TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
ALDX

Aldeyra Therapeutics, Inc.

Healthcare · Biotechnology

1.20$ -1.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Aldeyra Therapeutics, Inc. (ALDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 48 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ALDX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
147 148 141 126 117 105 93 85 78 72 66 48
147 148 141 126 117 104 93 85 77 72 66 47
143 143 102 71 68 55 50 41 59 70 65 45
143 143 133 120 113 101 90 82 75 70 65 45
– – 50 40 40 – 0.8 – – – – –
24 29 28 28 32 34 30 30 29 28 24 9.7
22 22 22 28 17 19 14 30 28 28 24 9.7
14 15 15 15 0.5 0.3 0.3 15 15 16 16 0.1
0.2 1.3 0.3 0.3 0.2 0.2 0.3 1.5 0.0 0.2 0.1 0.1
2.7 – – – 15 15 15 – – – – –
123 120 113 98 85 71 64 55 49 44 42 38
-390 -394 -402 -419 -434 -450 -460 -470 -477 -484 -487 -493
59 59 59 59 60 59 60 60 60 60 60 60

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?